The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss
Author: Berkeley Lovelace Jr.
This post was originally published on NBC News.
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss
This post was originally published on NBC News.